BioCentury | Aug 3, 2015
Company News

Eolas, AstraZeneca deal

...HCRTR1 ; OX1R ) antagonist program, which is in preclinical testing for smoking cessation. Eolas...
...plus undisclosed royalties. AZ declined to provide further details, and Eolas could not be reached. Eolas Therapeutics Inc....
Items per page:
1 - 1 of 1
BioCentury | Aug 3, 2015
Company News

Eolas, AstraZeneca deal

...HCRTR1 ; OX1R ) antagonist program, which is in preclinical testing for smoking cessation. Eolas...
...plus undisclosed royalties. AZ declined to provide further details, and Eolas could not be reached. Eolas Therapeutics Inc....
Items per page:
1 - 1 of 1